Literature DB >> 11728017

Activity of the cyclic depsipeptide emodepside (BAY 44-4400) against larval and adult stages of nematodes in rodents and the influence on worm survival.

A Harder1, G von Samson-Himmelstjerna.   

Abstract

The present investigations deal with the activity of the cyclic depsipeptide emodepside (BAY 44-4400) against larval and adult stages of three rodent nematodes. While emodepside acts strongly against the adult stages of the rat nematodes Nippostrongylus brasiliensis and Strongyloides ratti, as well as against the mouse nematode Heligmosomoides polygyrus, its actions against the larval stages of these nematodes vary according to the species. Thus, emodepside is highly effective against the lung and intestine larval stages of N. brasiliensis and S. ratti. By contrast. the larval stages of H. polygyrus in the intestine are only partly affected by higher emodepside dosages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11728017     DOI: 10.1007/s004360100479

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  6 in total

1.  A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.

Authors:  Melanie Abongwa; Richard J Martin; Alan P Robertson
Journal:  Acta Vet (Beogr)       Date:  2017-06-26       Impact factor: 0.800

2.  Sensitivity of Haemonchus contortus to anthelmintics using different in vitro screening assays: a comparative study.

Authors:  Beatriz Munguía; Jenny Saldaña; Magdalena Nieves; María Elisa Melian; Manuela Ferrer; Ramiro Teixeira; Williams Porcal; Eduardo Manta; Laura Domínguez
Journal:  Parasit Vectors       Date:  2022-04-12       Impact factor: 3.876

Review 3.  Development of emodepside as a possible adulticidal treatment for human onchocerciasis-The fruit of a successful industrial-academic collaboration.

Authors:  Jürgen Krücken; Lindy Holden-Dye; Jennifer Keiser; Roger K Prichard; Simon Townson; Benjamin L Makepeace; Marc P Hübner; Steffen R Hahnel; Ivan Scandale; Achim Harder; Daniel Kulke
Journal:  PLoS Pathog       Date:  2021-07-22       Impact factor: 6.823

4.  Strongyloides ratti: in vitro and in vivo activity of tribendimidine.

Authors:  Jennifer Keiser; Kai Thiemann; Yvette Endriss; Jürg Utzinger
Journal:  PLoS Negl Trop Dis       Date:  2008-01-23

5.  Safety, tolerability and pharmacokinetics of emodepside, a potential novel treatment for onchocerciasis (river blindness), in healthy male subjects.

Authors:  Jean-Yves Gillon; Jeremy Dennison; Frans van den Berg; Sophie Delhomme; Karen Dequatre Cheeseman; Claudia Peña Rossi; Nathalie Strub Wourgaft; Sabine Specht; Belén Pedrique; Frédéric Monnot; Susanne Skrabs; Maria-Luisa Rodriguez; Heino Stass
Journal:  Br J Clin Pharmacol       Date:  2021-03-31       Impact factor: 4.335

6.  Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside.

Authors:  Frauke Assmus; Richard M Hoglund; Frédéric Monnot; Sabine Specht; Ivan Scandale; Joel Tarning
Journal:  PLoS Negl Trop Dis       Date:  2022-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.